I think that when doctors get their DEA license to prescribe controlled and potentially addictive medications, they should mandatory be taught how to use a prescription drug monitoring system.
Diana DeGette
The Public Record
Diana Louise DeGette is a U.S. Representative for Colorado's 1st congressional district, having served since January 3, 1997. A member of the Democratic Party, she has been a prominent advocate for health care reform and women's rights throughout her tenure in Congress. DeGette has played a significant role in various legislative efforts, particularly in expanding access to health care services. Her work has garnered support from organizations such as the National Association of Community Health Centers.
Not only are you going to have a failure rate, but you are also going to have deaths.
This is exactly what I have been trying to say is, it is not a one-size-fits-all solution for these patients
I really appreciate this panel coming. Congresswoman Brooks and I were saying during the vote how extremely helpful we thought all of your testimony was.
The Department of Justice has actually said in its discretionary grant program for drug courts that drug courts need to use these medication-assisted programs as part of it because it really is medicine, not drug addiction.
The number I heard is that over 100 million Americans could potentially be at risk from these cyber attacks
The Federal Government and also private businesses have been targeted by cybercriminals
Thank you, Mr. Chairman. I am glad we are having the time to do a deep dive into this important topic.
It is disrespectful to the witnesses and it undermines this committee's grand tradition.
I was appalled at the way two of the new Members of this subcommittee, Mr. Mullin and Mr. Collins, conducted themselves today.
I look forward to hearing our witnesses' testimony today because they are very familiar with the report and the issues that it raises.
We have nearly 44 million individuals, almost 19 percent of all U.S. adults, living with mental illness every year.
I want to hear about how we can ensure that Federal programs actually assist people who need them.
HHS, in rejecting both of GAO's recommendations, is essentially saying there is no room for improvement.
HHS rejected them both. In each instance, HHS dismissed GAO's concerns rather than presenting evidence to dispute GAO's conclusions.
No Federal agency has had a more central role in the disaster than the Department of Health and Human Services.
I completely agree with the Chairman, but I will say I want to commend this panel and others at the CDC and NIH.
What we need to do is come together in support of a strong public health infrastructure that prevents outbreaks.
I am really happy that our first hearing of this new Congress is on an area of bipartisan concern and interest.





